GlobalData Boosts Healthcare Insights with Deallus Acquisition
Deal News | Jan 07, 2025 | EIN
GlobalData Plc, a prominent data and analytics company based in London, has acquired Deallus, a competitive intelligence solutions provider specializing in the life sciences sector, from private equity firm Archimed. Deallus, known for its deep sector expertise in healthcare disciplines like oncology, neuroscience, and vaccines, will merge with GlobalData Healthcare to create a comprehensive platform offering unmatched data and insights in the life sciences industry. This acquisition marks GlobalData Healthcare's first since receiving investment from private equity firm Inflexion in June 2024. As a result, Deallus's expertise will amplify GlobalData's offerings, fostering deeper client relationships and leveraging artificial intelligence (AI) to provide enhanced analytics. The acquisition emphasizes GlobalData's commitment to becoming a leader in strategic healthcare intelligence, with the transaction finalized on December 31, 2024.
Sectors
- Healthcare and Life Sciences
- Data and Analytics
- Private Equity
Geography
- United Kingdom – GlobalData Plc and Deallus, both based in London, reflect the UK-centric nature of this acquisition.
Industry
- Healthcare and Life Sciences – The industry is relevant due to Deallus's focus on providing competitive intelligence solutions specifically in the global life sciences sector.
- Data and Analytics – This industry classification is pertinent because GlobalData is a data and analytics company, and the acquisition aligns with expanding its capabilities in healthcare data.
- Private Equity – This sector is important as private equity firm Archimed was the seller of Deallus, and Inflexion is an investor in GlobalData.
Financials
- – The article does not disclose the financial terms of the acquisition.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| GlobalData Plc | Bidding Companybuyer | Company | A leading data and analytics company based in London, acquiring Deallus. |
| Deallus | Target Company | Company | A competitive intelligence solutions provider focused on the life sciences sector, based in London. |
| Archimed | Selling Company | Company | A private equity firm that sold Deallus to GlobalData. |
| Inflexion | Investor | Company | A private equity firm that invested in GlobalData in June 2024, facilitating growth and acquisitions. |
| Mike Danson | CEO of GlobalData | Person | Provided commentary on the strategic alignment and benefits of the acquisition. |
| Peter Hempshall | CEO of Deallus | Person | Commented on the excitement and strategic future with GlobalData. |